Lauren Green

With funding meant to bolster basic research and help make advances for a variety of conditions the fate of the 21st Century Cure Act is anything but secure even after passage by the US House of Representatives.

A recent NY district court ruling and action by the Idaho House of Representatives have implications for Plan B dispensing.

Key members of Congress say they hope to pass health care reform this summer as surveys show Americans are skipping medicines and other treatments to save money.

Under a bill just introduced in the Senate, drug imports may become legal.

New research shows that drug facts boxes are an effective way to help patients make informed choices about their prescription medications.

Poll finds more patients are choosing generic over brand name drugs and shopping for them at discount stores and online.

Health information technology would get a boost under proposed economic stimulus plans, but providers urge caution over hasty enactment of new privacy mandates.

The General Accounting Office has added FDA's regulation and oversight of medical products to its biennial list of high-risk areas needing special attention by the new Congress.

The government reports slower growth in spending for prescription drugs in 2007, as a new survey finds many Americans extending their medications to save money.

New FDA-sponsored research on how helpful the information accompanying new prescriptions is for patients, finds that the handouts still do not meet Congressional goals for usefulness.

Medicare Part D open enrollment ends December 31—premium increases and complex plan descriptions may spur questions from your patients.

A new study has identified a list of widely prescribed medications that should be evaluated to determine how safe and effective they are for their off-label uses.

The JUPITER study ended more than 2 years early after an "unequivocal benefit of rosuvastatin" was determined among individuals with normal cholesterol levels but elevated levels of high-sensitivity C-reactive protein.

Too many Americans still smoke, and stress from current economic woes is making quitting even harder. Today’s Great American Smokeout marks a good time for pharmacists to step up those antismoking efforts.

The government has found that new cases of diabetes rose by more than 90% among adults over the last 10 years; helping patients prevent and manage this disease is a top priority for pharmacists.

A new project will help 100,000 pharmacists and students across the country learn more about the fast-growing field of pharmacogenomics.

A new survey shows that patients want more information and their doctors' approval before being asked to exchange one prescription for another.

Congress approves legislation to stop controlled substances from being sold online without a valid prescription.

Crime rings that target pharmacies would face federal penalties under bills now pending in Congress.

Study finds patients' adherence to cholesterol-reducing medications is influenced by the number of authorized refills per prescription.

The FDA's new system for quarterly reporting of potential drug safety issues to the public is now available

For help responding to patient inquiries about MRSA, the CDC has launched a major new information campaign to help protect against these infections.

As 2008 moves into its final quarter, pharmacists may encounter some of their patients forgoing needed Rxs because they are caught in Medicare's Part D coverage gap.

Health officials are concerned about a spike in measles cases imported from abroad among patients who did not get vaccinated.

Medicare will pay bonuses to providers who use e-prescribing, a move expected to reduce medication errors and save millions in costs due to adverse drug events.

The CDC's 10-year survey shows rise in health care visits, but today's economic woes are making some Americans cut back on prescriptions and dosages to make their medications last longer.

The overall number of Internet pharmacies has dropped in the past year, but the problem of obtaining controlled substances without a prescription is not going away.

The American Academy of Pediatrics is now recommending cholesterol-reducing medications for high-risk kids.

The CDC looks to improve the nation's health through more proactive prevention and wellness policies.